Atlanta, GA, United States of America

Sherif R Zaki


Average Co-Inventor Count = 24.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sherif R Zaki: Innovator in Coronavirus Research

Introduction

Sherif R Zaki is a prominent inventor based in Atlanta, GA, known for his significant contributions to the field of virology. He has been instrumental in the research and isolation of coronaviruses, particularly in relation to severe acute respiratory syndrome (SARS). With a total of 2 patents, his work has had a profound impact on public health and disease detection.

Latest Patents

Zaki's latest patents focus on a newly isolated human coronavirus (SARS-CoV), which is the causative agent of SARS. The patents disclose the nucleic acid sequence of the SARS-CoV genome and the amino acid sequences of the SARS-CoV open reading frames. Additionally, they provide methods for using these molecules to detect SARS-CoV and diagnose infections. Immune stimulatory compositions are also included, along with methods for their application in medical research and treatment.

Career Highlights

Sherif R Zaki works at the National Institutes of Health, a component of the US Department of Health & Human Services. His career has been marked by a commitment to advancing our understanding of viral infections and developing innovative methods for their detection and treatment.

Collaborations

Zaki has collaborated with notable colleagues in his field, including Paul A Rota and Larry J Anderson. These partnerships have further enhanced the impact of his research and contributed to the advancement of virology.

Conclusion

Sherif R Zaki's work in isolating coronaviruses and developing detection methods has made him a key figure in the fight against viral diseases. His contributions continue to influence public health initiatives and research in virology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…